cagrisema semaglutide cagrilintide combination trial Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes Weight Loss Efficacy of Cagrilintide

This dual-receptor design is meant to combine appetite suppression with a metabolic push that GLP-1-only compounds dont provide on their own

Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells

HSA and FSA accounts qualify for payment, making treatment more accessible

Rapid weight loss creates specific challenges that the medication itself does not solve

SPECIAL REPORTBRAIN HEALTH IN AMERICA: UNDERSTANDING AND SUPPORTING LIFELONG COGNITIVE HEALTH As more Americans live into their late 70s and beyond, public interest in proactively building and maintaining brain health is growing

Mood enhancement Vitamin B12 plays a role in producing serotonin, a hormone that regulates mood